Clinical Trial Update: The Vascutek Custom Fenestrated Anaconda Post-Market Surveillance Study

View source ↗

Summary

Post-market surveillance trial for the Vascutek Custom Fenestrated Anaconda abdominal aortic aneurysm stent graft has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Abdominal Aortic Aneurysm

Drugs mentioned

• Vascutek Custom Fenestrated Anaconda

Snippet

Sponsor: Vascutek Ltd. | Conditions: Abdominal Aortic Aneurysms (AAA) | Status: TERMINATED